The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on July 21, 2026

Jul. 21, 2026

Critical Metals Corp Advances to Final Round of Kenya Government Tender for the World-Class Mrima Hill Rare Earth and Niobium Project

Indeterminate GlobeNewswire

Jul. 21, 2026

OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire

Jul. 21, 2026

Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program

Indeterminate GlobeNewswire

Jul. 21, 2026

Bitget Launches Industry-First Quanto Perpetual Futures for TradFi Assets

Indeterminate GlobeNewswire

Jul. 21, 2026

Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity

Indeterminate GlobeNewswire

Jul. 21, 2026

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Indeterminate GlobeNewswire

Jul. 21, 2026

Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions

Indeterminate GlobeNewswire

Jul. 21, 2026

AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement

Indeterminate GlobeNewswire

Jul. 21, 2026

Vaxart to Participate in BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 21, 2026

NIOB Seigneurie Assays Confirm Niobium Mineralization in hole seven

Indeterminate GlobeNewswire

Jul. 21, 2026

R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis

Indeterminate GlobeNewswire

Jul. 21, 2026

Tecnoglass Sets Date for Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 21, 2026

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

Indeterminate GlobeNewswire

Jul. 21, 2026

Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

Jul. 21, 2026

NexGold Continues to Advance Key Development Activities at the Goldboro Gold Project in Nova Scotia

Indeterminate GlobeNewswire

Jul. 21, 2026

OKYO Pharma Announces Purchase of Shares by Chairman

Indeterminate GlobeNewswire

Jul. 21, 2026

Discovery Confirms Presence of Large-Scale Deposit at Pamour

Indeterminate GlobeNewswire

Jul. 21, 2026

Proposed Name Change and Consolidation of Capital

Indeterminate GlobeNewswire

Jul. 21, 2026

Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting

Indeterminate GlobeNewswire

Jul. 21, 2026

OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA

Indeterminate GlobeNewswire